ChemicalBook >> CAS DataBase List >>dupilumab

dupilumab

CAS No.
1190264-60-8
Chemical Name:
dupilumab
Synonyms
REGN-668;dupilumab;Dupliumab;SAR-231893;Research Grade Dupilumab(DHD62601)
CBNumber:
CB24919920
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
Last updated:2024-07-02 08:55:04

dupilumab Properties

form Liquid
color Colorless to light yellow
FDA UNII 420K487FSG
NCI Drug Dictionary dupilumab
ATC code D11AH05

dupilumab price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0030874 Dupilumab ≥99.2% 1190264-60-8 1mg $900 2021-12-16 Buy
ChemScene CS-0030874 Dupilumab ≥99.2% 1190264-60-8 5mg $1800 2021-12-16 Buy
ChemScene CS-0030874 Dupilumab ≥99.2% 1190264-60-8 25mg $9000 2021-12-16 Buy
Product number Packaging Price Buy
CS-0030874 1mg $900 Buy
CS-0030874 5mg $1800 Buy
CS-0030874 25mg $9000 Buy

dupilumab Chemical Properties,Uses,Production

Uses

Dupilumab, also known as Dupixent?, is a treatment for severe atopic eczema.

Mechanism of action

Biologics work by blocking ILs from binding to their cell receptors (protein molecules that receive chemical signals from outside a cell); this stops the immune system from overreacting. Dupilumab works on two specific ILs thought to contribute to atopic conditions: IL-4 and IL-13. By blocking IL-4 and IL-13 from binding to their cell receptors, dupilumab limits the overreaction of the immune system, dampening down the chronic inflammatory response and lessening the symptoms of atopic eczema.

Pharmacokinetics

Dupilumab shows a non-linear rate in regard to the target.Dupilumab is also reported to have a bioavailability of 64%, with the average concentration occurring one week after in one week after injection.

Side effects

The most common side effects reported by the US Food and Drug Administration (FDA) include injection site reactions, upper respiratory tract infections, joint pain, and herpes viral infections.The most common side effects reported by the European Medicines Agency (EMA) include injection-site reactions (such as redness, swelling including due to fluid build-up, itching and pain), conjunctivitis (redness and discomfort in the eye) including conjunctivitis due to allergy, joint pain, cold sores, and increased blood levels of a type of white blood cell called eosinophils.

dupilumab Preparation Products And Raw materials

Raw materials

Preparation Products

dupilumab Suppliers

Global( 24)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
Wuhan Jingkang en Biomedical Technology Co., Ltd
+8613720134139 orders@jknbiochem.com China 4692 58
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266 China 4197 55
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9708 58
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994 2853530910@QQ.com China 8018 62
Shanghai Zhibang Biological Medicine Co., LTD 021-54285032 18116461626 25493162@qq.com China 142 58
Fan De(Beijing) Biotechnology Co., Ltd. 15911056312 liming@bio-fount.com China 9730 58
BOC Sciences -- info@bocsci.com USA 0 65
Guangzhou Hongyuan Chemical Co.,Ltd 15817493340 981810490@qq.com China 1565 58
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062 422450190@qq.com China 10034 58
dupilumab REGN-668 SAR-231893 Research Grade Dupilumab(DHD62601) Dupliumab 1190264-60-8